Evidence map›Paper›PMID 29752412›Full record

ArticleThe Journal of biological chemistry2018

Properly folded and functional PorB from

Weiyan Zhu, Joshua Tomberg, Kayla J Knilans, James E Anderson, Karen P McKinnon, Gregory D Sempowski, Robert A Nicholas, Joseph A Duncan

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Influence of cervicovaginal microbiota onMicrobial cell (Graz, Austria) · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Mechanisms of host manipulation byFrontiers in microbiology · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Quantitative Proteomics of the 2016 WHOMolecular & cellular proteomics : MCP · 2019
    Article
  17. Review
  18. Review
  19. Pathogenesis ofFrontiers in immunology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Weiyan ZhuFrom the Department of Medicine, Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina 27599.
Joshua Tombergthe Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27599.
Kayla J Knilansthe Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27599.
James E AndersonFrom the Department of Medicine, Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina 27599.
Karen P McKinnonthe Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina 27599, and.
Gregory D Sempowskithe Department of Medicine and Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina 27710.
Robert A Nicholasthe Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27599, nicholas@med.unc.edu.
Joseph A DuncanFrom the Department of Medicine, Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina 27599, jaduncan@med.unc.edu.ORCID 0000-0002-4438-2018
University of North Carolina at Chapel Hill · USDuke Medical Center · US

Funding

Trichomonas Typing SystemU19AI031496 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SPARLING, PHILIP FREDERICK · 1995 to 2014
$24.9M
Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
Training in Sexually Transmitted Infections and HIVT32AI007001 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SENA-SOBERANO, ARLENE C. · 1985 to 2025
$10.9M
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (ACU19AI113170 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI JERSE, ANN E. · 2014 to 2018
$6.9M
Supplement to Molecular Targets in Peptidoglycan SynthesisR01GM066861 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DAVIES, CHRISTOPHER · 2003 to 2019
$5.4M
NIAID NIH HHS T32 AI007001NIAID NIH HHS U19 AI031496NIAID NIH HHS U19 AI113170NIAID NIH HHS UC6 AI058607NIGMS NIH HHS R01 GM066861
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell ProliferationProtein FoldingCD4-Positive T-LymphocytesCells, CulturedDendritic CellsGonorrheaHumansLymphocyte ActivationNeisseria gonorrhoeaePorinsSignal TransductionToll-Like Receptor 2porin protein, NeisseriaPorinsTLR2 protein, humanToll-Like Receptor 2dendritic cellimmunosuppressionNeisseria gonorrhoeaeouter membraneouter membrane vesicleporinT cellToll-like receptor 2 (TLR2)Toll-like receptor (TLR)

Identifiers

PMID29752412
PMCPMC6052219
OpenAlexW2800091690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.